These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

238 related items for PubMed ID: 19173823

  • 21. Arsenic trioxide exerts synergistic effects with cisplatin on non-small cell lung cancer cells via apoptosis induction.
    Li H, Zhu X, Zhang Y, Xiang J, Chen H.
    J Exp Clin Cancer Res; 2009 Aug 08; 28(1):110. PubMed ID: 19664237
    [Abstract] [Full Text] [Related]

  • 22. Chloroquine potentiates the anti-cancer effect of lidamycin on non-small cell lung cancer cells in vitro.
    Liu F, Shang Y, Chen SZ.
    Acta Pharmacol Sin; 2014 May 08; 35(5):645-52. PubMed ID: 24727941
    [Abstract] [Full Text] [Related]

  • 23. Antitumor activity of erlotinib (OSI-774, Tarceva) alone or in combination in human non-small cell lung cancer tumor xenograft models.
    Higgins B, Kolinsky K, Smith M, Beck G, Rashed M, Adames V, Linn M, Wheeldon E, Gand L, Birnboeck H, Hoffmann G.
    Anticancer Drugs; 2004 Jun 08; 15(5):503-12. PubMed ID: 15166626
    [Abstract] [Full Text] [Related]

  • 24. Antitumor activity of selective MEK1/2 inhibitor AZD6244 in combination with PI3K/mTOR inhibitor BEZ235 in gefitinib-resistant NSCLC xenograft models.
    Qu Y, Wu X, Yin Y, Yang Y, Ma D, Li H.
    J Exp Clin Cancer Res; 2014 Jun 17; 33(1):52. PubMed ID: 24939055
    [Abstract] [Full Text] [Related]

  • 25. TNF-related apoptosis-inducing ligand enhances vinorelbine-induced apoptosis and antitumor activity in a preclinical model of non-small cell lung cancer.
    Zhu K, Fang W, Chen Y, Lin S, Chen X.
    Oncol Rep; 2014 Sep 17; 32(3):1234-42. PubMed ID: 25017445
    [Abstract] [Full Text] [Related]

  • 26. Brucea javanica Increases Survival and Enhances Gemcitabine Efficacy in a Patient-derived Orthotopic Xenograft (PDOX) Mouse Model of Pancreatic Cancer.
    Yang H, Tong Z, Shen L, Sun YU, Hoffman RM, Huang J.
    Anticancer Res; 2020 Sep 17; 40(9):4969-4978. PubMed ID: 32878785
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Gefitinib and chemotherapy combination studies in five novel human non small cell lung cancer xenografts. Evidence linking EGFR signaling to gefitinib antitumor response.
    Judde JG, Rebucci M, Vogt N, de Cremoux P, Livartowski A, Chapelier A, Tran-Perennou C, Boye K, Defrance R, Poupon MF, Bras-Gonçalves RA.
    Int J Cancer; 2007 Apr 01; 120(7):1579-90. PubMed ID: 17205515
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Histology and sensitivity to anticancer drugs of two human non-small cell lung carcinomas implanted in the pleural cavity of nude mice.
    Kraus-Berthier L, Jan M, Guilbaud N, Naze M, Pierré A, Atassi G.
    Clin Cancer Res; 2000 Jan 01; 6(1):297-304. PubMed ID: 10656461
    [Abstract] [Full Text] [Related]

  • 31. Preclinical combination chemotherapy of nedaplatin with gemcitabine against gemcitabine-refractory human lung cancer.
    Takeda Y, Wada T, Nishitani Y, Matsumoto M, Hojo K, Maekawa R, Yoshioka T.
    Cancer Lett; 2002 Aug 08; 182(1):61-8. PubMed ID: 12175524
    [Abstract] [Full Text] [Related]

  • 32. Development of Optimized, Inhalable, Gemcitabine-Loaded Gelatin Nanocarriers for Lung Cancer.
    Youngren-Ortiz SR, Hill DB, Hoffmann PR, Morris KR, Barrett EG, Forest MG, Chougule MB.
    J Aerosol Med Pulm Drug Deliv; 2017 Oct 08; 30(5):299-321. PubMed ID: 28277892
    [Abstract] [Full Text] [Related]

  • 33. Biweekly cisplatin and gemcitabine with two different doses in non small cell lung cancer patients: A retrospective singlecenter experience.
    Dogan E, Ucar M, Sakalar T, Derin S, Bozkurt O, Inanc M, Ozkan M.
    J BUON; 2018 Oct 08; 23(4):1070-1076. PubMed ID: 30358213
    [Abstract] [Full Text] [Related]

  • 34. [A randomized comparative trial of three combined regimens containing cisplatin for treatment of advanced non-small cell lung cancer].
    Liu L, Wang XW, Li L, Zhang X, Zhang WD, Yu XJ.
    Ai Zheng; 2006 Aug 08; 25(8):990-4. PubMed ID: 16965680
    [Abstract] [Full Text] [Related]

  • 35. Synergistic activity of combination therapy with PEGylated pemetrexed and gemcitabine for an effective cancer treatment.
    Vandana M, Sahoo SK.
    Eur J Pharm Biopharm; 2015 Aug 08; 94():83-93. PubMed ID: 25968494
    [Abstract] [Full Text] [Related]

  • 36. Influence of cisplatin-use, age, performance status and duration of chemotherapy on symptom control in advanced non-small cell lung cancer: detailed symptom analysis of a randomised study comparing cisplatin-vindesine to gemcitabine.
    Vansteenkiste J, Vandebroek J, Nackaerts K, Dooms C, Galdermans D, Bosquée L, Delobbe A, Deschepper K, Van Kerckhoven W, Vandeurzen K, Deman R, D'Odemont JP, Siemons L, Van den Brande P, Dams N, Leuven Lung Cancer Group.
    Lung Cancer; 2003 May 08; 40(2):191-9. PubMed ID: 12711121
    [Abstract] [Full Text] [Related]

  • 37. Gemcitabine (GEM) and carboplatin (CBDCA) versus cisplatin (CDDP) and vinblastine (VLB) in advanced non-small-cell lung cancer (NSCLC) stages III and IV: a phase III randomised trial.
    Grigorescu AC, Draghici IN, Nitipir C, Gutulescu N, Corlan E.
    Lung Cancer; 2002 Jul 08; 37(1):9-14. PubMed ID: 12057861
    [Abstract] [Full Text] [Related]

  • 38. Docetaxel/gemcitabine or cisplatin/gemcitabine followed by docetaxel in the first-line treatment of patients with metastatic non-small cell lung cancer (NSCLC): results of a multicentre randomized phase II trial.
    Binder D, Schweisfurth H, Grah C, Schäper C, Temmesfeld-Wollbrück B, Siebert G, Suttorp N, Beinert T.
    Cancer Chemother Pharmacol; 2007 Jun 08; 60(1):143-50. PubMed ID: 17031643
    [Abstract] [Full Text] [Related]

  • 39. Does the sequence of gemcitabine and vinorelbine affect their efficacy in non-small cell lung cancer in vitro?
    De Luca A, Grassii M, Maiello MR, Di Maio M, Mancino M, De Maio E, Gridelli C, Perrone F, Normanno N.
    Anticancer Res; 2004 Jun 08; 24(5A):2985-9. PubMed ID: 15517905
    [Abstract] [Full Text] [Related]

  • 40. Bufalin induces apoptosis in vitro and has Antitumor activity against human lung cancer xenografts in vivo.
    Wu SH, Bau DT, Hsiao YT, Lu KW, Hsia TC, Lien JC, Ko YC, Hsu WH, Yang ST, Huang YP, Chung JG.
    Environ Toxicol; 2017 Apr 08; 32(4):1305-1317. PubMed ID: 27444971
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.